Parnell Residing Science is happy to announce the launch of RESPIRmycin, a ready-to-use injectable answer containing 100 mg of tulathromycin/mL, a trusted antibiotic to deal with and management bovine respiratory illness (BRD) in cattle, foot rot and pinkeye, in addition to swine respiratory illness
The prescription antibiotic, lately authorized for Parnell by the FDA, is the newest addition to the injectable portfolio of bovine options supplied by Parnell. RESPIRmycin is manufactured in Parnell’s FDA authorized facility and meets all prime quality and security requirements.
“Parnell is happy to supply RESPIRmycin to veterinarians and producers as an answer to respiratory illness in cattle,” stated Pablo Lamberto, DVM, president of U.S. operations at Parnell Residing Science. “This addition to Parnell’s current merchandise and applied sciences provide prospects the identical high quality they’ve skilled with our acknowledged cattle reproductive answer portfolio together with GONAbreed, estroPLAN and mySYNCH.”
Lamberto continued, “Launching RESPIRmycin demonstrates the dedication of Parnell to assist veterinarians and producers frequently enhance livestock well being by adhering to the rules of accountable antimicrobial use: Illness prevention, correct prognosis and efficient therapy.”
RESPIRmycin is indicated to be used in beef cattle (together with suckling calves), non-lactating dairy cattle (together with dairy calves), veal calves, and swine. It’s not to be used in feminine dairy cattle 20 months of age or older.
Beef and non-lactating dairy cattle
BRD – RESPIRmycin Injectable Resolution is indicated for the therapy of bovine respiratory illness (BRD) related to Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis; and for the management of respiratory illness in cattle at excessive danger of growing BRD related to M. haemolytica, P. multocida, H. somni and M. bovis.
IBK – RESPIRmycin Injectable Resolution is indicated for the therapy of infectious bovine keratoconjunctivitis (IBK) related to Moraxella bovis.
Foot Rot – RESPIRmycin Injectable Resolution is indicated for the therapy of bovine foot rot (interdigital necrobacillosis) related to Fusobacterium necrophorum and Porphyromonas levii.
Suckling calves, dairy calves, and veal calves
BRD – RESPIRmycin Injectable Resolution is indicated for the therapy of BRD related to M. haemolytica, P. multocida, H. somni and M. bovis.
Swine
RESPIRmycin Injectable Resolution is indicated for the therapy of swine respiratory illness (SRD) related to Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica, Haemophilus parasuis and Mycoplasma hyopneumoniae; and for the management of SRD related to A. pleuropneumoniae, P. multocida and M. hyopneumoniae in teams of pigs the place SRD has been identified.
RESPIRmycin is at present obtainable in 50 mL and 100 mL bottles.
